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httpcense.Abstract Patients with COPD and bronchial asthma have been reported to have an increase in the
energy cost of breathing which is reﬂected by changes in their basal metabolic rates (BMR).
Aim: To assess the changes that may occur in basal metabolic rates in patients with bronchial
asthma and those with chronic obstructive pulmonary disease.
Patients and methods: We used indirect calorimetry using oro-nasal mask to assess the BMR in 35
patients with COPD, 20 patients with bronchial asthma and 10 healthy volunteers (control group).
Results: There was marked increase in basal metabolic rates in patients with COPD compared to
patients with bronchial asthma (p value 60.001) and to the control group (p value 60.001), also
between asthmatic patients and control group (p value 60.05). The BMR also showed a highly sig-
niﬁcant negative correlation (p value 60.001) with the level of hypoxemia and pulmonary functions
(the severity of the disease) in both COPD and asthmatic patients.
Conclusion: Patients with COPD and bronchial asthma have increased metabolic rates. These
increased rates are directly correlated to the severity of the diseases and the impairment in the respi-
ratory function.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Malnutrition and weight loss are common ﬁndings in patients
with chronic obstructive pulmonary disease (COPD) and bron-est Department, Menouﬁya
le: +20 1004774422.
oo.com (M.A. Agha).
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of Chest Diseases and Tuberculos
://dx.doi.org/10.1016/j.ejcdt.2013.0chial asthma. Low body weight have been shown to be associ-
ated with increased mortality with reduced survival [1].
Almost 50% of all COPD patients become underweight,
and several studies have shown that a low body mass index
(BMI) or body composition with low fat-free mass index
(FFMI), is a major mortality risk factor [2].
When weight loss does occur, it is associated with a de-
crease in respiratory muscle strength and endurance, decreased
diaphragmatic size, as well as increased incidence of cor pul-
monale [3].
The cachexia observed in patients with COPD was attrib-
uted to a reduced caloric intake presumably due to breathless-
ness limiting food consumption. Recently, however, it has beenis. Production and hosting by Elsevier B.V.
1.007
40 M.A. Agha, R.A. El Wahshshown that these patients often have seemingly adequate calo-
ric intake suggesting that the weight loss may be due to an in-
crease in energy expenditure [4].
Resting energy expenditure (REE) is often increased and
may contribute towards energy imbalance in patients with
chronic pulmonary diseases. Energy expenditure may be ele-
vated due to increased basal metabolic rate, increased activity
expenditure, or an increase in nutrient-induced thermogenesis
[5].
The REE is typically divided into basal metabolic rate,
which is normally the largest component of REE (>60% of
REE), thermogenesis (mainly dietary induced thermogenesis,
which accounts for about 10% of energy expenditure) and
physical activity energy expenditure (PAEE) [6].
Patients with COPD have been reported to have a raised
BMR, partly because of an increase in the energy cost of
breathing. However, there is no universal agreement on this is-
sue. Traditionally, it has been explained on the basis of an in-
creased oxygen consumption of the respiratory muscles due to
the increased work of breathing that characterizes the disease.
However, it has been recently shown that skeletal non-respira-
tory muscle oxygen consumption is higher at any given load in
patients with COPD than in age-matched healthy controls,
indicating that bioenergetic abnormalities are also present in
non-respiratory muscles, and that these abnormalities proba-
bly contribute to the increased metabolic rate in patients with
COPD [7].
Several mechanisms could conceivably contribute to the in-
creased metabolic rate in bronchial asthma and COPD. First,
drugs commonly used in the treatment (e.g. B2-agonists) can
increase metabolic rate. Second, systemic inﬂammation could
also play a signiﬁcant role. Third, tissue hypoxia which may
also make a contribution, since other diseases characterized
by tissue hypoxia, such as congestive heart failure, show in-
creased metabolic rate [2].
Aim
The aim of the current study was to assess the changes that
may occur in basal metabolic rates in patients with bron-
chial asthma and those with chronic obstructive pulmonary
disease.Subject and methods
The present study included 55 patients (35 patients with COPD
and 20 patients had bronchial asthma) admitted to chest
department, Menouﬁya University hospitals in the period
from February 2012 to August 2012. We also included 10
healthy non smoker subjects who volunteered as a control
group.
Criteria of exclusion
Any patient suffering from other medical conditions,
metabolic or endocrinal disorders was excluded from the
study.
After having an informed consent from the patients, they
underwent history taking, clinical examination, and radiologi-
cal examination of the chest (P–A view).Pulmonary function tests were done for all studied patients.
Patients with COPD were classiﬁed according to GOLD 2010
[8] classiﬁcation into mild, moderate, severe and very severe.
Arterial blood gases (partial pressure of oxygen (Pa O2) and
partial pressure of carbon dioxide (Pa CO2) were measured in
all patients.
The weight and height of the subjects were measured and
used to calculate the body mass index (BMI). BMI was calcu-
lated as weight (kg) divided by height2 (m2).
BMR measurement using indirect calorimetry
BMR was measured by indirect calorimetry using oronasal
mask. The equipment used was a Quark BMR (COSMED,
Chicago, USA). Before starting test the device and the analyz-
ers should be calibrated according to the manufacturer’s
instructions before each measurement [9].
– The subjects were informed not to eat for at least 12 h or
smoke for at least 2 h before the test.
– The subjects were instructed to limit their physical activity
the evening before the measurement.
– The measurements were performed in an environmental
temperature between 22 and 23 C.
– After a 30 min rest in the supine position, BMR was mea-
sured during 30 min when the subjects were awake in the
supine position.
– The ﬁrst 5 min of data acquisition was discarded when per-
forming the test. The presented mean BMR for each patient
is based on the last 25 min of the measurement.
– A steady state during the test was established when a 5 min
of average oxygen uptake through the lung (VO2) and the
amount of carbon dioxide expelled to atmosphere (VCO2)
changes by less than 10% and the average respiratory Quo-
tient (RQ) changes by less than 5%.Statistical analysis
Data were collected, tabulated, statistically analyzed by com-
puter using SPSS version 16.
Descriptive statistics
Quantitative data are expressed to measure the central ten-
dency of data and diversion around the mean, mean (x) and
standard deviation (SD).
Qualitative data expressed in number and percentage.
Analytic statistics
 Students T test was used for comparison of two quantitative
variables.
 Krauskal Wallis test was used for comparison of more than
two groups, LSD post hoc test was used to detect the inter-
group differences.
 Pearson correlation (r) was used to detect association
between quantitative variables.
 Chi square test was used for comparison of qualitative
variables.
 p value >0.05 was considered statistically non signiﬁcant.
 p value 60.05 was considered statistically signiﬁcant.
 p value 60.01 was considered statistically highly signiﬁcant.
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There was marked increase in basal metabolic rates in patients
with COPD compared to patients with bronchial asthma and
to the control group, also between asthmatic patients and con-
trol group. The BMR also showed a highly signiﬁcant negative
correlation with the level of hypoxemia and pulmonary func-
tions (the severity of the disease) in both COPD and asthmatic
patients.
Tables 1–5 show results of this study.
Discussion
Nutritional abnormalities, including alterations in caloric in-
take, basal metabolic rate, intermediate metabolism, and body
composition, are common in COPD. It is unlikely that these
abnormalities are due to decreased caloric intake, which does
not appear to be prominent in these patients except during epi-
sodes of exacerbation of the disease. In contrast, most patients
with COPD have changes in basal metabolic rate, which often
result in weight loss [5]. A few studies related to the changes
that also may occur in patients with bronchial asthma are pres-
ent, theses studies showed changes in basal metabolic rate
either increased especially during the attacks or decreased
mostly due to associated hormonal abnormalities [10–12].
So, the aim of this work was to assess changes in basal met-
abolic rates that occur in patients with bronchial asthma and
those with COPD.
In the present study there was a highly signiﬁcant difference
(p value 60.001) between the ages of COPD patients and those
of both bronchial asthma and the control group while the dif-
ference between the ages of patients with bronchial asthma and
the control group was non signiﬁcant (p value >0.05) (Ta-
ble 1). According to GOLD guidelines, COPD should be sus-
pected in any patient aged 40 years or more with symptoms of
cough, sputum production, or breathlessness and/or a history
of exposure to risk factors, in particular smoking [13]. Fletcher
and Peto [14] reported that COPD is characterized by an accel-
erated rate of decline of FEV1 with age. According to this, one
might expect patients with severe COPD to be older. AlthoughTable 1 Statistical comparison between COPD, bronchial asthma a
Variable COPD n= 35 Bronchial asthma n=
Age Mean ± SD 60.54 ± 7.29 39.75 ± 10.51
Gender Male 25 8
Female 10 12
Smoking habit Active smoker 22 7
Passive smoker 8 6
Non smoker 5 7
Smoking index Mean ± SD 297.14 ± 252.91 105 ± 152.95
BMI Mean ± SD 20.89 ± 3.92 22.25 ± 3.23
FEV1 Mean ± SD 58.74 ± 19.08 66.9 ± 13.17
PO2 Mean ± SD 66.83 ± 14.23 75.05 ± 9.73
BMR Mean ± SD 114.06 ± 15.23 102.1 ± 5.58
* means statistically signiﬁcant.
** means statistically highly signiﬁcant.bronchial asthma is not rare in the elderly population,
it has been considered a disease of childhood and young adults
[10].
In the present work, there was a highly signiﬁcant differ-
ence between COPD and asthmatic patients regarding the
smoking habits (p value 60.001). This is in agreement with
the study of Laniado-Laborı´n [15], who stated that smoking
is the most important causative factor for development of
COPD and that lifelong smokers have a 50% probability of
developing COPD during their lifetime.
In the present study, there was a highly signiﬁcant increase
in BMR in COPD patients and to a lesser extent in the asth-
matic patients. There was a highly signiﬁcant difference (p va-
lue 60.001) between COPD and both asthmatic patients and
control group while there was a signiﬁcant difference (p value
60.05) between asthmatic and control group (Table 1).
These results are in agreement with the results of Goldistein
et al. [16] who found that energy expenditure was greater than
predicted (116%) in patients with COPD and less than pre-
dicted (90%) in the control group.
Also, Hugli et al. [17] in their study showed that patients
with stable COPD are characterized by a normal daily energy
expenditure in controlled conditions in spite of an increased
basal metabolic rate. They concluded that COPD patients ap-
pear to save energy by reducing their spontaneous level of
physical activity. They found that BMR increased (137–
145% of predicted) in their studied group.
Creutzberg et al. [7] supported the previous ﬁndings and
concluded that hypermetabolism commonly occurs in COPD.
They suggested contribution of an elevated oxygen cost of
breathing (OCB) to hypermetabolism in COPD.
Slinde et al. [18] found that measured BMR was higher in
the COPD group than the controllers. The median values for
BMR was 103% of predicted in patients with COPD versus
99.7% of predicted in control group. They concluded in their
study that patients with moderate-to-severe COPD tend to
have higher BMR than normal subjects matched for age and
habits. These results were explained by the inﬂuence of COPD
associated mediators, chronic low-grade inﬂammation, hypox-
ia, hormonal alterations, medications and physical activity.nd control groups in different parameters.
20 Control group n= 10 p value
COPD vs.
bronchial asthma
COPD vs.
control
Bronchial
asthma vs.
control
41.7 ± 14.99 60.001** 60.001** >0.05
6 >0.05 >0.05 >0.05
4
>0.05
60.001**
22.4 ± 1.26 >0.05 >0.05 >0.05
>0.05
60.05*
89.4 ± 1.51 60.001** 60.001** 60.05*
Table 2 Pearson correlation between BMR and different
parameters in all studied persons (n= 65).
Age BMI
r p value r p value
BMR 0.51 60.001** 0.55 60.001**
** means statistically highly signiﬁcant.
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60.05) between BMR in patients with bronchial asthma and
the control group. These ﬁndings are in accordance with that
of Zeitlin et al. [10] who found that the mean BMR of the asth-
matic group was signiﬁcantly greater than controls. Also, Maf-
feis et al. [19] measured energy intake (EI) and total energy
expenditure (TEE) of asthmatic males, they found that resting
energy expenditure (REE) adjusted for fat-free mass was high-
er in asthmatic than in non asthmatic males. They concluded
that males with mild-to-moderate asthma had a higher
metabolic activity per unit fat-free mass than non asthmatic
males.
The studies which disagreed with this work and showed de-
creased BMR in asthmatic patients explained their ﬁndings by
the increased numbers of patients with hypothyroidism in their
selected asthmatic patients group [11,12].
Moreover, there are conﬂicting data on the relation be-
tween BMI and bronchial asthma severity. Tavasoli et al.
[20] found that with increasing asthma severity, they observed
higher occurrence of obesity in adults. They concluded that the
association of asthma severity with obesity suggests that obes-
ity may be a potentially modiﬁable risk factor for asthma or
asthma exacerbation.
On the other hand, Nadi et al. [21], in their study on asth-
matic patients, observed negative association between BMI
and asthma severity.
Regarding the parameters affecting the BMR in all studied
persons, we found that there was a highly signiﬁcant correla-
tion (p value 60.001) between BMR and the age and BMI
(Table 2).
Starvation and weight loss have long been associated with a
decrease in metabolic rate. However, patients with respiratory
disease have an elevated metabolic rate even when malnour-
ished [2].Table 3 Statistical comparison between different COPD severity gr
Parameter Mild COPD
(I) n= 7
Moderate
COPD (II) n= 13
Severe C
(III) n=
Age (mean ± SD) 58.7 ± 7.4 57.1 ± 6.5 64.9 ± 6
Gender Male 4 6
Female 3 7
Smoking habit Active 2 5
Passive 3 5
Non smoker 2 3
Smoking index (mean ± SD) 135.7 ± 232.2 134.6 ± 190.8 555.6 ±
BMI (mean ± SD) 20.4 ± 1.8 24.4 ± 4.1 18.3 ± 1
PO2 (mean ± SD) 78.6 ± 7.1 76 ± 5.3 52.7 ± 7
BMR (mean ± SD) 106 ± 3.1 102.9 ± 7.2 127.9 ±The present work showed that BMR differed signiﬁcantly
between different grades of COPD severity, with a signiﬁcant
increase in BMR with increasing severity of the disease
(Table 3). Also, there was a signiﬁcant positive correlation
(p value 60.05) regarding COPD patients between BMR and
age, and a highly signiﬁcant positive correlation (p value
60.001) between the BMR and the smoking index, while there
was a highly signiﬁcant negative correlation between BMR
with the BMI, FEV1 and level of hypoxemia (Table 4).
Nordenson et al. [22] stated that COPD patients who are
underweight or are losing weight involuntarily have a higher
mortality rate than other patients with COPD. Among pa-
tients with FEV1 of less than 35% predicted, 50% were under-
nourished. Thus, severity of airway obstruction increases the
risk of undernutrition. Almost 50% of all COPD patients be-
come underweight, and a low body mass index (BMI) is a ma-
jor mortality risk factor.
Moreover, Donahoe et al. [23] studied 10 malnourished and
9 normally nourished patients with COPD and 7 control sub-
jects. They found that BMR was elevated (>120% normal) in
malnourished patients with COPD. Also, in malnourished pa-
tients, the oxygen cost of breathing was signiﬁcantly higher
than in the normally nourished and control group subjects.
Therefore, it has been postulated that increased REE in under-
nourished patients with COPD is in part due to increased oxy-
gen cost of breathing. Other possible mechanisms of the
increased metabolic rate in patients with COPD regarding
the severity may include: increased ventilatory requirements,
inefﬁcient use of the respiratory muscles, and possibly the ef-
fects of sympathomimetics such as theophylline and beta
agonists.
The previous ﬁndings are supported by Ramires et al. [24]
who found that the COPD group had lower BMI than control,
and elderly patients with COPD had higher BMR.
Choi and Pai [25] investigated the association between
respiratory functions and BMR. Pulmonary function indices
and BMR were measured in 251 elderly persons. They con-
cluded that respiratory function is more closely associated with
BMR in elderly persons.
The present study showed that regarding asthmatic pa-
tients, there was a non signiﬁcant correlation (p value
>0.05) between BMR and the age of patients, their BMI or
their smoking index (Table 5), this may explained by the large
number of asthmatic patients who were young and non smok-ades in different parameters.
OPD
9
Very severe
COPD
(IV) n= 6
p value
I vs. II I vs. III I vs. IV II vs. III II vs. IV III vs.
IV
.2 63.7 ± 7.1 >0.05 >0.05 >0.05 60.05 >0.05 >0.05
9 6 60.05
0 0
9 6 60.05
0 0
0 0
84.6 450 ± 134.2 >0.05 60.01 60.05 60.001 60.01 >0.05
.3 17.7 ± 1.2 60.01 60.05 60.01 60.001 60.001 >0.05
.5 54.5 ± 14.3 >0.05 60.001 60.01 60.001 60.05 >0.05
8.4 127 ± 19.2 >0.05 60.001 60.05 60.001 60.05 >0.05
Table 4 Pearson correlation between BMR and different parameters in COPD patients (n= 35).
Age Smoking index BMI FEV1 PaO2
R p value R p value r p value r p value R p value
BMR 0.36 60.05* 0.52 60.001** 0.62 60.001** 0.68 60.001** 0.86 60.001**
* means statistically signiﬁcant.
** means statistically highly signiﬁcant.
Table 5 Pearson correlation between BMR and different parameters in bronchial asthma patients (n= 20).
Age Smoking index BMI FEV1 PaO2
R p value r p value r p value r p value R p value
BMR 0.13 >0.05 0.14 >0.05 0.44 >0.05 0.85 60.001** 0.83 60.001**
** means statistically highly signiﬁcant.
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60.001) between BMR and both PO2 and FEV1.
To our knowledge, BMR was not extensively studied in
asthmatic patients, however it could be postulated that severe
degree of bronchial asthma especially if affecting oxygenation
would affect metabolic rates by the same mechanisms as in
COPD patients.
Conclusion
Basal metabolic rate increases in patients with COPD and
bronchial asthma but with marked increase in the COPD
patients.
In COPD patients, BMR levels are directly correlated to the
severity of the disease including level of arterial oxygen ten-
sions and pulmonary functions. Smoking increases the BMR
in COPD patients either through its direct effects or through
increasing the severity of the disease.
Special interest should be directed towards assessment of
nutritional and metabolic status in chronic respiratory dis-
eased patients especially COPD, and special nutritional inter-
ventions should be planned to improve general condition
and performance in such patients.
More studies should be done for more evaluation of
changes in BMR in bronchial asthma.
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